Long-term impact of primary prophylaxis on joint status in patients with severe hemophilia A

[1]  E. Santagostino,et al.  WFH Guidelines for the Management of Hemophilia, 3rd edition , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  M. Recht,et al.  Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study. , 2020, Blood advances.

[3]  S. Israels,et al.  Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study , 2020, Research and practice in thrombosis and haemostasis.

[4]  P. Babyn,et al.  Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort. , 2018, The Lancet. Haematology.

[5]  V. Jiménez‐Yuste,et al.  The value of HEAD-US system in detecting subclinical abnormalities in joints of patients with hemophilia , 2018, Expert review of hematology.

[6]  J. Gill,et al.  Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project. , 2017, Blood.

[7]  Z. Başlar,et al.  Personalized prophylaxis in people with hemophilia A: challenges and achievements , 2016, Expert review of hematology.

[8]  M. Schuurmans,et al.  Defining adherence to prophylaxis in haemophilia , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  V. Blanchette,et al.  When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH , 2016, Journal of thrombosis and haemostasis : JTH.

[10]  B. Bartels,et al.  Using routine Haemophilia Joint Health Score for international comparisons of haemophilia outcome: standardization is needed , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  J. Oldenburg.  Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. , 2015, Blood.

[12]  R. Ljung,et al.  Various regimens for prophylactic treatment of patients with haemophilia , 2015, European journal of haematology.

[13]  R. Ljung,et al.  Definitions in hemophilia: communication from the SSC of the ISTH , 2014, Journal of thrombosis and haemostasis : JTH.

[14]  L. Valentino.  Considerations in individualizing prophylaxis in patients with haemophilia A , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[15]  P. Mannucci,et al.  Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  L. Valentino,et al.  Towards personalizing haemophilia care: using the Haemophilia Severity Score to assess 178 patients in a single institution , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  R. Ljung,et al.  Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. , 2013, Blood.

[18]  A. Bianchi,et al.  Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A. , 2013, Blood.

[19]  M. Morfini,et al.  Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) , 2013, Thrombosis and Haemostasis.

[20]  A. Miners,et al.  Models of prophylaxis , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[21]  M. Franchini,et al.  Prophylaxis in Children with Hemophilia: Evidence-Based Achievements, Old and New Challenges , 2012, Seminars in Thrombosis & Hemostasis.

[22]  J. Astermark,et al.  Physical activity and joint function in adults with severe haemophilia on long-term prophylaxis , 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[23]  M. Volta,et al.  Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: identification of 23 new mutations , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[24]  V. Blanchette,et al.  Prophylaxis in the haemophilia population , 2010, Haemophilia.

[25]  R. Liesner,et al.  A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A , 2010, British journal of haematology.

[26]  M. Clerici,et al.  Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile , 2010, Journal of thrombosis and haemostasis : JTH.

[27]  R. Ljung.  Prophylactic therapy in haemophilia. , 2009, Blood reviews.

[28]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[29]  P. D. de Groot,et al.  Phenotypic heterogeneity in severe hemophilia , 2007, Journal of thrombosis and haemostasis : JTH.

[30]  S. Donadel-Claeyssens.  Current co‐ordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management) , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[31]  M. Quintana,et al.  Prophylactic treatment effects on inhibitor risk: experience in one centre , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

[32]  H. Chambost,et al.  Towards the goal of prophylaxis: experience and treatment strategies from Sweden, France and Hungary , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[33]  P. Petrini.  How to start prophylaxis , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[34]  I. Warrier,et al.  The overall effectiveness of prophylaxis in severe haemophilia , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[35]  A. Shapiro.  A global view on prophylaxis: possibilities and consequences , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[36]  J. Astermark,et al.  Consensus perspectives on prophylactic therapy for haemophilia: summary statement , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[37]  K. Fischer,et al.  Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[38]  A. Miners,et al.  Experience of prophylaxis treatment in children with severe haemophilia , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[39]  F. Beek,et al.  Long‐term outcome of individualized prophylactic treatment of children with severe haemophilia , 2001, British journal of haematology.

[40]  P. Petrini.  What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B? , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[41]  Sultan,et al.  Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[42]  J. Astermark,et al.  Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized , 1999, British journal of haematology.

[43]  C. Kessler,et al.  When should prophylactic treatment in patients with haemophilia A and B start?— The German experience , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[44]  R. Kaufman,et al.  Moderation of hemophilia A phenotype by the factor V R506Q mutation. , 1996, Blood.

[45]  P. Mannucci,et al.  Modern treatment of haemophilia. , 1995, Bulletin of the World Health Organization.

[46]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.